# Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

> **NCT06221813** · PHASE1 · COMPLETED · sponsor: **Public Health Vaccines LLC** · enrollment: 120 (actual)

## Conditions studied

- Nipah Virus Infection

## Interventions

- **BIOLOGICAL:** PHV02
- **BIOLOGICAL:** Lactated Ringer's

## Key facts

- **NCT ID:** NCT06221813
- **Lead sponsor:** Public Health Vaccines LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-26
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-10-02
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06221813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06221813, "Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06221813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*